[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Nanopharmaceuticals Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

January 2020 | 152 pages | ID: N8D483300A57EN
99Strategy

US$ 3,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
SUMMARY

Further key aspects of the report indicate that:

Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.

The global Nanopharmaceuticals market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.

Based on the type of product, the global Nanopharmaceuticals market segmented into
  • Liposomes
  • Polymeric Micelles
  • Solid Lipid Nanoparticles
  • Microemulsion And Nanoemulsion
  • Nanosuspension
Based on the end-use, the global Nanopharmaceuticals market classified into
  • Cancer
  • Tumor
  • Autoimmune Disorders
Based on geography, the global Nanopharmaceuticals market segmented into
  • North America [U.S., Canada, Mexico]
  • Europe [Germany, UK, France, Italy, Rest of Europe]
  • Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
  • South America [Brazil, Argentina, Rest of Latin America]
  • Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
  • Merck
  • Pfizer
  • Novartis
  • Abbott
  • GlaxoSmithKline
  • Roche
  • Sanofi
  • Eli Lilly
  • Astrazeneca
  • Johnson & Johnson
  • Celgene
  • Novavax
  • Stryker
  • Gilead Sciences
  • OSI Pharmaceuticals
  • Kadmon Pharmaceuticals
  • Samyang Biopharm
  • Mitsubishi Pharma
  • Kaken Pharmaceutical
  • Selecta Biosciences
  • Par Pharmaceutical
  • Cerulean Pharma
  • Navidea Biopharmaceuticals
  • Lummy
1 RESEARCH SCOPE

1.1 Research Product Definition
1.2 Research Segmentation
  1.2.1 Product Type
  1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology

2 GLOBAL NANOPHARMACEUTICALS INDUSTRY

2.1 Summary about Nanopharmaceuticals Industry
2.2 Nanopharmaceuticals Market Trends
  2.2.1 Nanopharmaceuticals Production & Consumption Trends
  2.2.2 Nanopharmaceuticals Demand Structure Trends
2.3 Nanopharmaceuticals Cost & Price

3 MARKET DYNAMICS

3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
  3.2.1 Drivers
  3.2.2 Restraints
  3.2.3 Opportunity
  3.2.4 Risk

4 GLOBAL MARKET SEGMENTATION

4.1 Region Segmentation (2017 to 2021f)
  4.1.1 North America (U.S., Canada and Mexico)
  4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
  4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
  4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
  4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
  4.2.1 Liposomes
  4.2.2 Polymeric Micelles
  4.2.3 Solid Lipid Nanoparticles
  4.2.4 Microemulsion And Nanoemulsion
  4.2.5 Nanosuspension
4.3 Consumption Segmentation (2017 to 2021f)
  4.3.1 Cancer
  4.3.2 Tumor
  4.3.3 Autoimmune Disorders

5 NORTH AMERICA MARKET SEGMENT

5.1 Region Segmentation (2017 to 2021f)
  5.1.1 U.S.
  5.1.2 Canada
  5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
  5.2.1 Liposomes
  5.2.2 Polymeric Micelles
  5.2.3 Solid Lipid Nanoparticles
  5.2.4 Microemulsion And Nanoemulsion
  5.2.5 Nanosuspension
5.3 Consumption Segmentation (2017 to 2021f)
  5.3.1 Cancer
  5.3.2 Tumor
  5.3.3 Autoimmune Disorders
5.4 Impact of COVID-19 in North America

6 EUROPE MARKET SEGMENTATION

6.1 Region Segmentation (2017 to 2021f)
  6.1.1 Germany
  6.1.2 UK
  6.1.3 France
  6.1.4 Italy
  6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
  6.2.1 Liposomes
  6.2.2 Polymeric Micelles
  6.2.3 Solid Lipid Nanoparticles
  6.2.4 Microemulsion And Nanoemulsion
  6.2.5 Nanosuspension
6.3 Consumption Segmentation (2017 to 2021f)
  6.3.1 Cancer
  6.3.2 Tumor
  6.3.3 Autoimmune Disorders
6.4 Impact of COVID-19 in Europe

7 ASIA-PACIFIC MARKET SEGMENTATION

7.1 Region Segmentation (2017 to 2021f)
  7.1.1 China
  7.1.2 India
  7.1.3 Japan
  7.1.4 South Korea
  7.1.5 Southeast Asia
  7.1.6 Australia
  7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
  7.2.1 Liposomes
  7.2.2 Polymeric Micelles
  7.2.3 Solid Lipid Nanoparticles
  7.2.4 Microemulsion And Nanoemulsion
  7.2.5 Nanosuspension
7.3 Consumption Segmentation (2017 to 2021f)
  7.3.1 Cancer
  7.3.2 Tumor
  7.3.3 Autoimmune Disorders
7.4 Impact of COVID-19 in Europe

8 SOUTH AMERICA MARKET SEGMENTATION

8.1 Region Segmentation (2017 to 2021f)
  8.1.1 Brazil
  8.1.2 Argentina
  8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
  8.2.1 Liposomes
  8.2.2 Polymeric Micelles
  8.2.3 Solid Lipid Nanoparticles
  8.2.4 Microemulsion And Nanoemulsion
  8.2.5 Nanosuspension
8.3 Consumption Segmentation (2017 to 2021f)
  8.3.1 Cancer
  8.3.2 Tumor
  8.3.3 Autoimmune Disorders
8.4 Impact of COVID-19 in Europe

9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION

9.1 Region Segmentation (2017 to 2021f)
  9.1.1 GCC
  9.1.2 North Africa
  9.1.3 South Africa
  9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
  9.2.1 Liposomes
  9.2.2 Polymeric Micelles
  9.2.3 Solid Lipid Nanoparticles
  9.2.4 Microemulsion And Nanoemulsion
  9.2.5 Nanosuspension
9.3 Consumption Segmentation (2017 to 2021f)
  9.3.1 Cancer
  9.3.2 Tumor
  9.3.3 Autoimmune Disorders
9.4 Impact of COVID-19 in Europe

10 COMPETITION OF MAJOR PLAYERS

10.1 Brief Introduction of Major Players
  10.1.1 Merck
  10.1.2 Pfizer
  10.1.3 Novartis
  10.1.4 Abbott
  10.1.5 GlaxoSmithKline
  10.1.6 Roche
  10.1.7 Sanofi
  10.1.8 Eli Lilly
  10.1.9 Astrazeneca
  10.1.10 Johnson & Johnson
  10.1.11 Celgene
  10.1.12 Novavax
  10.1.13 Stryker
  10.1.14 Gilead Sciences
  10.1.15 OSI Pharmaceuticals
  10.1.16 Kadmon Pharmaceuticals
  10.1.17 Samyang Biopharm
  10.1.18 Mitsubishi Pharma
  10.1.19 Kaken Pharmaceutical
  10.1.20 Selecta Biosciences
  10.1.21 Par Pharmaceutical
  10.1.22 Cerulean Pharma
  10.1.23 Navidea Biopharmaceuticals
  10.1.24 Lummy
10.2 Nanopharmaceuticals Sales Date of Major Players (2017-2020e)
  10.2.1 Merck
  10.2.2 Pfizer
  10.2.3 Novartis
  10.2.4 Abbott
  10.2.5 GlaxoSmithKline
  10.2.6 Roche
  10.2.7 Sanofi
  10.2.8 Eli Lilly
  10.2.9 Astrazeneca
  10.2.10 Johnson & Johnson
  10.2.11 Celgene
  10.2.12 Novavax
  10.2.13 Stryker
  10.2.14 Gilead Sciences
  10.2.15 OSI Pharmaceuticals
  10.2.16 Kadmon Pharmaceuticals
  10.2.17 Samyang Biopharm
  10.2.18 Mitsubishi Pharma
  10.2.19 Kaken Pharmaceutical
  10.2.20 Selecta Biosciences
  10.2.21 Par Pharmaceutical
  10.2.22 Cerulean Pharma
  10.2.23 Navidea Biopharmaceuticals
  10.2.24 Lummy
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation

11 MARKET FORECAST

11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
  11.3.1 Impact of COVID-19
  11.3.2 Geopolitics Overview
  11.3.3 Economic Overview of Major Countries

12 REPORT SUMMARY STATEMENT
LIST OF TABLES
Table Nanopharmaceuticals Product Type Overview
Table Nanopharmaceuticals Product Type Market Share List
Table Nanopharmaceuticals Product Type of Major Players
Table Brief Introduction of Merck
Table Brief Introduction of Pfizer
Table Brief Introduction of Novartis
Table Brief Introduction of Abbott
Table Brief Introduction of GlaxoSmithKline
Table Brief Introduction of Roche
Table Brief Introduction of Sanofi
Table Brief Introduction of Eli Lilly
Table Brief Introduction of Astrazeneca
Table Brief Introduction of Johnson & Johnson
Table Brief Introduction of Celgene
Table Brief Introduction of Novavax
Table Brief Introduction of Stryker
Table Brief Introduction of Gilead Sciences
Table Brief Introduction of OSI Pharmaceuticals
Table Brief Introduction of Kadmon Pharmaceuticals
Table Brief Introduction of Samyang Biopharm
Table Brief Introduction of Mitsubishi Pharma
Table Brief Introduction of Kaken Pharmaceutical
Table Brief Introduction of Selecta Biosciences
Table Brief Introduction of Par Pharmaceutical
Table Brief Introduction of Cerulean Pharma
Table Brief Introduction of Navidea Biopharmaceuticals
Table Brief Introduction of Lummy
Table Products & Services of Merck
Table Products & Services of Pfizer
Table Products & Services of Novartis
Table Products & Services of Abbott
Table Products & Services of GlaxoSmithKline
Table Products & Services of Roche
Table Products & Services of Sanofi
Table Products & Services of Eli Lilly
Table Products & Services of Astrazeneca
Table Products & Services of Johnson & Johnson
Table Products & Services of Celgene
Table Products & Services of Novavax
Table Products & Services of Stryker
Table Products & Services of Gilead Sciences
Table Products & Services of OSI Pharmaceuticals
Table Products & Services of Kadmon Pharmaceuticals
Table Products & Services of Samyang Biopharm
Table Products & Services of Mitsubishi Pharma
Table Products & Services of Kaken Pharmaceutical
Table Products & Services of Selecta Biosciences
Table Products & Services of Par Pharmaceutical
Table Products & Services of Cerulean Pharma
Table Products & Services of Navidea Biopharmaceuticals
Table Products & Services of Lummy
Table Market Distribution of Major Players
Table Global Major Players Sales Revenue (Million USD) 2017-2020e
Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
Table Global Nanopharmaceuticals Market Forecast (Million USD) by Region 2021f-2026f
Table Global Nanopharmaceuticals Market Forecast (Million USD) Share by Region 2021f-2026f
Table Global Nanopharmaceuticals Market Forecast (Million USD) by Demand 2021f-2026f
Table Global Nanopharmaceuticals Market Forecast (Million USD) Share by Demand 2021f-2026f
LIST OF FIGURES
Figure Global Nanopharmaceuticals Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Nanopharmaceuticals Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Nanopharmaceuticals Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Nanopharmaceuticals Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Nanopharmaceuticals Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Nanopharmaceuticals Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Nanopharmaceuticals Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Liposomes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Polymeric Micelles Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Solid Lipid Nanoparticles Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Microemulsion And Nanoemulsion Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Nanosuspension Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Tumor Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Autoimmune Disorders Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Liposomes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Polymeric Micelles Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Solid Lipid Nanoparticles Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Microemulsion And Nanoemulsion Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Nanosuspension Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Tumor Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Autoimmune Disorders Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Liposomes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Polymeric Micelles Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Solid Lipid Nanoparticles Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Microemulsion And Nanoemulsion Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Nanosuspension Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Tumor Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Autoimmune Disorders Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Liposomes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Polymeric Micelles Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Solid Lipid Nanoparticles Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Microemulsion And Nanoemulsion Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Nanosuspension Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Tumor Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Autoimmune Disorders Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Liposomes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Polymeric Micelles Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Solid Lipid Nanoparticles Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Microemulsion And Nanoemulsion Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Nanosuspension Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Tumor Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Autoimmune Disorders Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Liposomes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Polymeric Micelles Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Solid Lipid Nanoparticles Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Microemulsion And Nanoemulsion Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Nanosuspension Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Tumor Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Autoimmune Disorders Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Nanopharmaceuticals Sales Revenue (Million USD) of Merck 2017-2020e
Figure Nanopharmaceuticals Sales Revenue (Million USD) of Pfizer 2017-2020e
Figure Nanopharmaceuticals Sales Revenue (Million USD) of Novartis 2017-2020e
Figure Nanopharmaceuticals Sales Revenue (Million USD) of Abbott 2017-2020e
Figure Nanopharmaceuticals Sales Revenue (Million USD) of GlaxoSmithKline 2017-2020e
Figure Nanopharmaceuticals Sales Revenue (Million USD) of Roche 2017-2020e
Figure Nanopharmaceuticals Sales Revenue (Million USD) of Sanofi 2017-2020e
Figure Nanopharmaceuticals Sales Revenue (Million USD) of Eli Lilly 2017-2020e
Figure Nanopharmaceuticals Sales Revenue (Million USD) of Astrazeneca 2017-2020e
Figure Nanopharmaceuticals Sales Revenue (Million USD) of Johnson & Johnson 2017-2020e
Figure Nanopharmaceuticals Sales Revenue (Million USD) of Celgene 2017-2020e
Figure Nanopharmaceuticals Sales Revenue (Million USD) of Novavax 2017-2020e
Figure Nanopharmaceuticals Sales Revenue (Million USD) of Stryker 2017-2020e
Figure Nanopharmaceuticals Sales Revenue (Million USD) of Gilead Sciences 2017-2020e
Figure Nanopharmaceuticals Sales Revenue (Million USD) of OSI Pharmaceuticals 2017-2020e
Figure Nanopharmaceuticals Sales Revenue (Million USD) of Kadmon Pharmaceuticals 2017-2020e
Figure Nanopharmaceuticals Sales Revenue (Million USD) of Samyang Biopharm 2017-2020e
Figure Sales Revenue (Million USD) of Mitsubishi Pharma 2017-2020e
Figure Sales Revenue (Million USD) of Kaken Pharmaceutical 2017-2020e
Figure Sales Revenue (Million USD) of Selecta Biosciences 2017-2020e
Figure Sales Revenue (Million USD) of Par Pharmaceutical 2017-2020e
Figure Sales Revenue (Million USD) of Cerulean Pharma 2017-2020e
Figure Sales Revenue (Million USD) of Navidea Biopharmaceuticals 2017-2020e
Figure Sales Revenue (Million USD) of Lummy 2017-2020e


More Publications